Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma

This publication has 29 references indexed in Scilit:

• Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer
  Nature Clinical Practice Oncology, 2007
• Clinicopathologic Prognostic Factors in Myxoid Liposarcoma: A Retrospective Study of 49 Patients With Long-Term Follow-Up
  Annals of Surgical Oncology, 2006
• Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma
  Cancer Research, 2006
• The PIK3CA gene is mutated with high frequency in human breast cancers
  Cancer Biology & Therapy, 2004
• Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
  2001
• Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma
  Oncogene, 2000
• Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
  1997
• The clinicopathologic spectrum of myxoid and round cell liposarcoma: A study of 95 cases
  Cancer, 1996
• Myxoid/Round Cell Liposarcoma of the Extremities
  The American Journal of Surgical Pathology, 1996
• Liposarcoma A study of 55 cases with a reassessment of its classification
  The American Journal of Surgical Pathology, 1979